Clinical Trial Update: A Single Dose Study of Debio 1450 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a single dose of Debio 1450 in healthy subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Debio 1450

Snippet

Sponsor: Debiopharm International SA | Conditions: Bacterial Infections | Phase 1 | Status: COMPLETED